Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	66.14	1011.48	608.80
Graham Fair Price	53.85	100908.53	65588.19
PEG	-79.77	0.03	-0.12
Price/Book	29.71	0.45	0.34
Price/Cash Flow	-51.06	2.72	5.55
Prices/Earnings	-43.44	3.93	6.94
Price/Sales	-61.72	0.72	1.89
Price/FCF	-51.06	2.72	5.55
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-54.33	1.00	2.19
Operating Margin	-54.33	1.00	2.19
ROA	126.51	< 0.005	< 0.005
ROE	0.01	0.03	129.35
ROIC	0.07	0.12	67.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.09	-94.36
Dividends QOQ	0.03	-1.00	3822.76
EBIT QOQ	10.55	0.57	-94.57
EPS QOQ	-0.56	1.57	179.64
FCF QOQ	1.35	1.69	25.79
Revenue QOQ	1.03	2.44	136.83
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-156.14	0.00	inf
Days Sales Outstanding (DSO)	223.68	0.00	inf
Inventory Turnover	-0.58	0.00	inf
Debt/Capitalization	0.75	0.74	-0.62
Quick Ratio	-0.08	-0.22	-156.39
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	124080.59	126054.30	1.59
Cash	-102941.15	-127029.53	-23.40
Capex	-2417.19	-1693.51	29.94
Free Cash Flow	7712.23	20765.59	169.26
Revenue	22630.08	77905.11	244.25
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.40	0.46	15.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	520.26	908.29	74.58
Naive Interpretation	Member

06 - Financial Health · Bad

Rating